- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.06. | Recipharm channels 'multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand | ||
| 16.06. | Stealth BioTherapeutics removes cloak to become Mighty | ||
| 16.06. | PhRMA talks up the power of 'Medicines First' in new campaign | ||
| 15.06. | Germany backs off plan to install variable discount pricing on drugs: report | ||
| 15.06. | Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod | ||
| 15.06. | IQVIA taps AI to put overlooked prescribers on marketers' maps | ||
| 15.06. | Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield | ||
| 15.06. | Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion | ||
| 12.06. | FDA hearing on Amgen's Tavneos will include findings from an independent review | ||
| 12.06. | In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test | ||
| 12.06. | Lilly, Biogen, Eisai and Genentech sponsor new 'Let's Talk Alzheimer's' podcast | ||
| 11.06. | Genentech executes another round of layoffs, with 3 VPs axed | ||
| 11.06. | Novo reports data breach, tells clinical trial patients to 'remain vigilant' | ||
| 11.06. | J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win | ||
| 11.06. | Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure | ||
| 11.06. | Madrigal takes giant inflatable liver on US tour in disease awareness push | ||
| 11.06. | Olixir NY teams with Crohn's & Colitis Foundation for 'Spill Your Guts' campaign | ||
| 10.06. | Genentech and Novartis dish up food allergy microdrama series | ||
| 10.06. | Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters | ||
| 10.06. | Teva to lay off 250 at API unit as search for new owner drags on: report | ||
| 10.06. | Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery | ||
| 09.06. | WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban | ||
| 09.06. | Merck, Gilead score in effort to develop the first weekly HIV pill | ||
| 09.06. | As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AstraZeneca and Daiichi rivals | ||
| 09.06. | AstraZeneca reprimanded over LinkedIn likes once again |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.